参考文献/References:
[1]Choi D,Malick WA,Koenig W,et al. Familial hypercholesterolemia:challenges for a high-risk population:JACC focus seminar 1/3[J]. J Am Coll Cardiol,2023,81(16):1621-1632.[2]Geisterfer-Lowrance AAT,Kass S,Tanigawa G,et al. A molecular basis for familial hypertrophic cardiomyopathy:a β cardiac myosin heavy chain gene missense mutation[J]. Cell,1990,62(5):999-1006.[3]Chai AC,Cui M,Chemello F,et al. Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice[J]. Nat Med,2023,29(2):401-411.[4]Walsh R,Jurgens SJ,Erdmann J,et al. Genome-wide association studies of cardiovascular disease[J]. Physiol Rev,2023,103(3):2039-2055.[5]Heimlich JB,Bick AG. Somatic mutations in cardiovascular disease[J]. Circ Res,2022,130(1):149-161. [6]Libby P,Sidlow R,Lin AE,et al. Clonal hematopoiesis:crossroads of aging,cardiovascular disease,and cancer:JACC review topic of the week[J]. J Am Coll Cardiol,2019,74(4):567-577.[7]Young AL,Challen GA,Birmann BM,et al. Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults[J]. Nat Commun,2016,7(1):12484.[8]Steensma DP,Bejar R,Jaiswal S,et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes[J]. Blood,2015,126(1):9-16.[9]Mitchell E,Spencer Chapman M,Williams N,et al. Clonal dynamics of haematopoiesis across the human lifespan[J]. Nature,2022,606(7913):343-350. [10]Fuster JJ,MacLauchlan S,Zuriaga MA,et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice[J]. Science,2017,355(6327):842-847.[11]Sano S,Horitani K,Ogawa H,et al. Hematopoietic loss of Y chromosome leads to cardiac fibrosis and heart failure mortality[J]. Science,2022,377(6603):292-297. [12]Belizaire R,Wong WJ,Robinette ML,et al. Clonal haematopoiesis and dysregulation of the immune system[J]. Nat Rev Immunol,2023,23(9):595-610. [13]Terao C,Suzuki A,Momozawa Y,et al. Chromosomal alterations among age-related haematopoietic clones in Japan[J]. Nature,2020,584(7819):130-135.[14]Jaiswal S,Natarajan P,Silver AJ,et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease[J]. N Engl J Med,2017,377(2):111-121.[15]Haitjema S,Kofink D,van Setten J,et al. Loss of Y chromosome in blood is associated with major cardiovascular events during follow-up in men after carotid endarterectomy[J]. Circ Cardiovasc Genet,2017,10(4):e001544. [16]Dumanski JP,Rasi C,L?n M,et al. Smoking is associated with mosaic loss of chromosome Y[J]. Science,2015,347(6217):81-83.[17]Ljungstr? V,Mattisson J,Halvardson J,et al. Loss of Y and clonal hematopoiesis in blood—two sides of the same coin?[J]. Leukemia,2022,36(3):889-891.[18]Ouseph MM,Hasserjian RP,Dal Cin P,et al. Genomic alterations in patients with somatic loss of the Y chromosome as the sole cytogenetic finding in bone marrow cells[J]. Haematologica,2021,106(2):555.[19]Zhang Q,Zhao L,Yang Y,et al. Mosaic loss of chromosome Y promotes leukemogenesis and clonal hematopoiesis[J]. JCI insight,2022,7(3):e153768..[20]Genovese G,K?ler AK,Handsaker RE,et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence[J]. N Engl J Med,2014,371(26):2477-2487. [21]Jaiswal S,Fontanillas P,Flannick J,et al. Age-related clonal hematopoiesis associated with adverse outcomes[J]. N Engl J Med,2014,371(26):2488-2498.[22]Sano S,Oshima K,Wang Y,et al. Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1β/NLRP3 inflammasome[J]. J Am Coll Cardiol,2018,71(8):875-886. [23]B?me M,Desch S,Rosolowski M,et al. Impact of clonal hematopoiesis in patients with cardiogenic shock complicating acute myocardial infarction[J]. J Am Coll Cardiol,2022,80(16):1545-1556. [24]Yu B,Roberts MB,Raffield LM,et al. Association of clonal hematopoiesis with incident heart failure[J]. J Am Coll Cardiol,2021,78(1):42-52.[25]Zeiher A,Braun T. Mosaic loss of Y chromosome during aging[J]. Science,2022,377(6603):266-267.[26]Mas-Peiro S,Abplanalp WT,Rasper T,et al. Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement[J]. Eur Heart J,2023,44(21):1943-1952.[27]Dorsheimer L,Assmus B,Rasper T,et al. Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure[J]. JAMA Cardiol,2019,4(1):25-33.[28]Abplanalp WT,Cremer S,John D,et al. Clonal hematopoiesis–driver DNMT3A mutations alter immune cells in heart failure[J]. Circ Res,2021,128(2):216-228.[29]Assmus B,Cremer S,Kirschbaum K,et al. Clonal haematopoiesis in chronic ischaemic heart failure:prognostic role of clone size for DNMT3A-and TET2-driver gene mutations[J]. Eur Heart J,2021,42(3):257-265.[30]Kiefer KC,Cremer S,Pardali E,et al. Full spectrum of clonal haematopoiesis‐driver mutations in chronic heart failure and their associations with mortality[J]. ESC Heart Fail,2021,8(3):1873-1884.[31]Yura Y,Miura-Yura E,Katanasaka Y,et al. The cancer therapy-related clonal hematopoiesis driver gene Ppm1d promotes inflammation and non-ischemic heart failure in mice[J]. Circ Res,2021,129(6):684-698.[32]Sano S,Wang Y,Ogawa H,et al. TP53-mediated therapy-related clonal hematopoiesis contributes to doxorubicin-induced cardiomyopathy by augmenting a neutrophil-mediated cytotoxic response[J]. JCI insight,2021,6(13):e146076..[33]Min KD,Polizio AH,Kour A,et al. Experimental ASXL1-mediated clonal hematopoiesis promotes inflammation and accelerates heart failure[J]. J Am Heart Assoc,2022,11(19):e026154.[34]Zekavat SM,Viana-Huete V,Matesanz N,et al. TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease[J]. Nat Cardiovasc Res,2023,2(2):144-158. Sano S,Thel MC,Walsh K. Clonal hematopoiesis:the nonhereditary genetics of age-associated cardiovascular disease[J]. Curr Opin Cardiol,2023,38(3):201-206.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(4):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(4):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(4):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(4):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(4):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[6]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(4):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[7]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[8]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(4):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[9]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(4):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[10]韦莹 刘书旺 李蕾 崔鸣.生长分化因子-15在心房颤动中的研究进展[J].心血管病学进展,2019,(8):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
WEI Ying,LIU Shuwang,LI Lei,et al.Growth Differentiation Factor-15 in Development of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(4):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]